Citadel Advisors’s SCP & CO Healthcare Acquisition Company Unit SHACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-531,808
Closed -$5.36M 15074
2021
Q2
$5.36M Buy
531,808
+5,380
+1% +$53.9K ﹤0.01% 4284
2021
Q1
$5.25M Buy
+526,428
New +$5.36M ﹤0.01% 4148

Other funds holding SHACU

Citadel Advisors's SHACU Position: Q3 2021 in Review

Citadel Advisors sold out of SCP & CO Healthcare Acquisition Company Unit (SHACU) in Q3 2021, closing a stake of 531,808 shares — an estimated $5.36M sold.

Citadel Advisors first reported a position in SHACU in Q1 2021 and held it in 2 quarters. The position peaked at $5.36M in Q2 2021. 35 funds tracked by Wall St. Rank hold SHACU as of Q3 2021.

  • Citadel Advisors reported no remaining SCP & CO Healthcare Acquisition Company Unit position as of Q3 2021 after selling out during the quarter.
  • Citadel Advisors sold 531,808 SCP & CO Healthcare Acquisition Company Unit shares in Q3 2021, an estimated $5.36M.
  • Citadel Advisors first reported a position in SCP & CO Healthcare Acquisition Company Unit in Q1 2021 and held it in 2 quarters.
  • Citadel Advisors's SCP & CO Healthcare Acquisition Company Unit position peaked at $5.36M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Unit as of Q3 2021.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.